Author

Alex Francioni

Observed names: A Francioni, A. Francioni

Institutions: Luton and Dunstable University Hospital NHS Foundation Trust, Luton and Dunstable Hospital

Observed institutions: University Hospitals Birmingham NHS Foundation Trust, Luton and Dunstable University Hospital NHS Foundation Trust, Luton and Dunstable Hospital, John Radcliffe Hospital, Public Health England, National Institute for Health and Care Research, University of Oxford, Public Health Scotland, National Records of Scotland, Nepal Health Research Council, Oxford University Clinical Research Unit, Intensive Care National Audit & Research Centre, Oxford University Clinical Research Unit Indonesia

ORCID: 0009-0005-8495-0306

Observed ORCID: 0009-0005-8495-0306

OpenAlex ID: A5024039987

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 566

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 512

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 402

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 361

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 303

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 141

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 45

Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital

2016 · Keir Stone-Brown, Mahmood Naji, et al. · CNS Spectrums · 24

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 15

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 8

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 5

Intrapleural use of tissue plasminogen activator and DNase in management of pleural infection.

2023 · Prashanth Shetty, Alex Francioni, et al. · European Respiratory Journal · 2

Rheumatic conditions associated with interstitial lung diseases: real-world outcomes in a secondary care setting

2025 · Alex Francioni, Muhammad K Nisar, et al. · Monaldi Archives for Chest Disease

Management of connective tissue disease related interstitial lung diseases in a district general hospital.

2023 · Natasha Ramsundar, Alex Francioni, et al. · European Respiratory Journal

Ab0817 Can Rheumatic Conditions Associated Interstitial Lung Diseases Be Managed in a District General Hospital – Results From a Longitudinal Outcomes Survey

2021 · A. Francioni, J. Gnanapragasam, et al. · Annals of the Rheumatic Diseases

Works count: 16

Citation count: 2,384

H-index: 9

I10-index: 9